Pediatric Hematology/Oncology

University of Wisconsin

Questions discussed in this category

How do you choose first or second-line systemic therapy for fibrolamellar hepatocellular carcinoma?

What are there most evidence-based options?

1 Answer available

Papers discussed in this category

Proceedings of the National Academy of Sciences of the United States of America, 2015-11-03

Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.

Oncologist, 2020 Mar 10

Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.

Semin Diagn Pathol, 2016 Dec 23

Fibrolamellar carcinoma: A histologically unique tumor with unique molecular findings.

Related Topics in Pediatric Hematology/Oncology